Gabrielle Fernandes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gabrielle fernandes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gabrielle Fernandes Today - Breaking & Trending Today

Novocure to Report First Quarter 2021 Financial Results


Novocure to Report First Quarter 2021 Financial Results
Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2021 on Thursday, April 29, 2021, before the U.S. financial markets open. Novocure s management will host a conference call and webcast to discuss its financial results for the three months ended March 31, 2021, at 8 a.m. EDT on Thursday, April 29, 2021. Analysts and investors can participate in the conference call by dialing 855-442-6895 for domestic callers and 509-960-9037 for international callers, using the conference ID 2286525.
The webcast, earnings slides presented during the webcast and the corporate presentation can be accessed live from the Investor Relations page of Novocure s website, www.novocure.com/investor-relations, and will be available for at least 14 days following the call. Novocure has used, and intends to continue to use, its investor relations website, as a means of disclosing material non-publ ....

New York , United States , New Hampshire , Gabrielle Fernandes , Leigh Labrie , Exchange Commission , Investor Relations , Tumor Treating , Tumor Treating Fields , Annual Report , Private Securities Litigation Reform Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஹாம்ப்ஷயர் , கேப்ரியல் பெர்னாண்டஸ் , லே லாப்ரி , பரிமாற்றம் தரகு , முதலீட்டாளர் உறவுகள் , கட்டி சிகிச்சை , கட்டி சிகிச்சை புலங்கள் , ஆண்டு அறிக்கை , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,

NovoCure (NVCR) Q4 2020 Earnings Call Transcript


NovoCure (NVCR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
NovoCure (NASDAQ: NVCR)
Ladies and gentlemen, thank you for standing by, and welcome to the NovoCure fourth-quarter and full-year 2020 earnings conference call. [Operator instructions] Please be advised that today s conference is being recorded. [Operator instructions] I would now like to hand the conference over to your speaker today, Gabrielle Fernandes, director of investor relations. Thank you.
Please go ahead, ma am.
Gabrielle Fernandes
Director of Investor Relations
Good morning, everyone, and thank you for joining us to review NovoCure s fourth-quarter and full-year 2020 performance. I am joined on the phone by our executive chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for ....

Hong Kong , Optune Lua , Jason Wittes , Ely Benaim , Jason Bednar , Ashley Cordova , Ttfields Optune , Jason Wittes Northland , Pritesh Shah , Vijay Kumar , Gabrielle Fernandes , Larry Biegelsen , Greg Gilbert , Greg Gilbert Truist , Dan Clark Mizuho , Piper Sandler , Asaf Danziger , Dan Clark , Vijay Kumar Evercore , Jason Bednar Piper Sandler , Difei Yang , Swiss Federal Office Of Public Health , European Network For Gynecological Oncological , French Ministry Of Health , Wells Fargo , Motley Fool Novocure ,

Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update


Novocure Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update
Quarterly net income of $4.9 million with $0.05 in earnings per share
Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2020, highlighting revenue growth and financial strength as well as the advancement of the company s clinical and product development programs. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy, Tumor Treating Fields.
Fourth quarter 2020 highlights include:
Three Months Ended
(2)
5
(1) Adjusted EBITDA is a non-U.S. GAAP measurement of earnings before interest, taxes, depreciation, amortization and share-based compensation. ....

New York , United States , New Hampshire , Gabrielle Fernandes , Optune Lua , Jaclyn Stahl , William Doyle , Asaf Danziger , Exchange Commission , Tumor Treating , Tumor Treating Fields , Chief Executive , Greater China , Investor Relations , Annual Report , Private Securities Litigation Reform Act , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஹாம்ப்ஷயர் , கேப்ரியல் பெர்னாண்டஸ் , ஜாக்லின் ஸ்டால் , வில்லியம் டாய்ல் , பரிமாற்றம் தரகு , கட்டி சிகிச்சை , கட்டி சிகிச்சை புலங்கள் , தலைமை நிர்வாகி ,